This document discusses the history, present use, and future of combined contraceptives or "the pill". It describes how the pill was developed in the 1950s-60s using synthetic hormones like norethindrone and norethynodrel. Newer progestins were later introduced with fewer side effects. The document outlines the pharmacology of estrogen and progestin components, mechanisms of action, drug interactions, and medical eligibility criteria for pill use. It reviews cycle benefits, possible health benefits like cancer reduction, and newer contraceptive options including pills containing drospirenone and vaginal rings. The conclusion discusses decreasing estrogen content and developing new delivery methods as future prospects.